| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | 0.21 | 1e-08 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.16 | 1e-05 |
| mRNA | ML239 | CTRPv2 | pan-cancer | AAC | 0.15 | 2e-05 |
| mRNA | Imatinib | CTRPv2 | pan-cancer | AAC | 0.15 | 3e-05 |
| mRNA | ruxolitinib | GDSC1000 | pan-cancer | AAC | 0.14 | 6e-05 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.13 | 8e-05 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.13 | 9e-05 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
| mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.13 | 0.0003 |